Disease | hyperthermia |
Comorbidity | C0302592|cervical ca |
Sentences | 4 |
PubMedID- 20375815 | Conclusions: the risk to develop vesicovaginal and/or rectovaginal fistulae is high after curative radiotherapy with or without chemotherapy and/or hyperthermia in patients with stage iva cervical cancer. |
PubMedID- 25660155 | Conclusion: it is not feasible to combine lapatinib with fixed doses of cisplatin and hyperthermia in patients with recurrent cervical carcinoma in a previously irradiated area mainly because of increased cisplatin-related toxicity. |
PubMedID- 24156619 | Objective: this study aimed to evaluate the outcome of cisplatin-based chemotherapy with concurrent hyperthermia in patients with recurrent cervical cancer after radiotherapy and cisplatin. |
PubMedID- 22690721 | Objective: to evaluate the efficacy of neoadjuvant chemotherapy, followed by radiotherapy and concurrent hyperthermia (triple therapy) in patients with advanced-stage cervical cancer. |
Page: 1